Unexplained weight loss (UWL) represents a diagnostic challenge in clinical practice. Despite its association with underlying serious conditions, a structured approach to its evaluation is often lacking. This article aims to provide a comprehensive methodology to address this issue.
UWL, defined as a loss of more than 5% of body weight over 6-12 months without a known cause, is prevalent in 15-20% of older adults. It is associated with increased morbidity and mortality, often indicating underlying malignancy, gastrointestinal disorders, endocrine disorders, or psychiatric illnesses.
The initial evaluation should include a thorough history and physical examination. Clinicians should inquire about changes in diet, exercise, medication, and symptoms suggestive of systemic diseases. A comprehensive physical examination can reveal signs of chronic diseases or malignancies.
The diagnostic approach should be stepwise and cost-effective. Routine laboratory tests, including complete blood count, metabolic panel, thyroid function tests, and urinalysis, should be performed initially. If these tests are inconclusive, targeted imaging or endoscopic studies based on the patient's symptoms and signs should be considered.
Management should be tailored to the underlying cause. If a specific cause is identified, appropriate treatment should be initiated. In cases where no cause is found, the focus should be on symptom management and close monitoring for the emergence of potential underlying conditions.
UWL is a common yet challenging presentation in clinical practice. A systematic approach to its evaluation, starting from a thorough history and physical examination to a stepwise diagnostic approach, can help identify the underlying cause effectively and efficiently. Personalized management based on the identified cause can then be initiated, ensuring optimal patient care.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation